Bristol-Myers Squibb
BMY
#169
Rank
S$155.04 B
Marketcap
S$75.85
Share price
0.79%
Change (1 day)
26.30%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): S$5.81

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is S$5.83. In 2025 the company made an earnings per share (EPS) of S$4.46 an increase over its 2024 EPS that were of S-$5.70.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$5.8130.26%
2025S$4.46-178.28%
2024S-$5.70-213.92%
2023S$5.0130.2%
2022S$3.84-6.04%
2021S$4.09-179.29%
2020S-$5.16-281.37%
2019S$2.85-27.21%
2018S$3.91
2016S$3.44175.26%
2015S$1.25-19.83%
2014S$1.56-22.44%
2013S$2.0134.48%
2012S$1.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.62 47.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$6.77 16.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$0.92-84.29%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$7.55 29.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.85 583.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$22.42 284.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$2.55-56.18%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$3.04-47.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$1.28-78.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$9.18 57.52%๐Ÿ‡ฌ๐Ÿ‡ง UK